Illumina: The Genome Revolution | Golden Age

Illumina, founded in 1998 by David Walt, John Stuelpnagel, Anthony Czarnik, and others, has been at the forefront of the genomics revolution. With its innovative sequencing technologies, such as the HiSeq and NovaSeq platforms, Illumina has enabled researchers to decode the human genome and beyond, with a significant impact on fields like medicine, agriculture, and synthetic biology. The company's influence extends to the Human Genome Project, cancer research, and genetic disease diagnosis, with over 90% of the world's sequencing data generated on Illumina machines. However, Illumina's dominance has also raised concerns about the concentration of power in the genomics industry and the potential for biased or incomplete data. As the field continues to evolve, Illumina's role in shaping the future of genomics and precision medicine will be crucial. With a Vibe score of 85, Illumina is a cultural and scientific force to be reckoned with, influencing the work of researchers like Jennifer Doudna and David Haussler, and companies like Regeneron and Biogen.